These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 15515406)
81. Treatment of fibromyalgia with tropisetron, a 5HT3 serotonin antagonist: a pilot study. Papadopoulos IA; Georgiou PE; Katsimbri PP; Drosos AA Clin Rheumatol; 2000; 19(1):6-8. PubMed ID: 10752491 [TBL] [Abstract][Full Text] [Related]
82. [5-HT3 receptor antagonists as a new therapeutic principle in rheumatology?]. Pongratz D Z Rheumatol; 2001 Feb; 60(1):47-8. PubMed ID: 11263014 [No Abstract] [Full Text] [Related]
83. The Human Serotonin Type 3 Receptor Gene (HTR3A-E) Allelic Variant Database. Celli J; Rappold G; Niesler B Hum Mutat; 2017 Feb; 38(2):137-147. PubMed ID: 27763704 [TBL] [Abstract][Full Text] [Related]
85. Serotonin type 3 receptor genes: HTR3A, B, C, D, E. Niesler B; Kapeller J; Hammer C; Rappold G Pharmacogenomics; 2008 May; 9(5):501-4. PubMed ID: 18466097 [TBL] [Abstract][Full Text] [Related]
86. The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications. Greenshaw AJ; Silverstone PH Drugs; 1997 Jan; 53(1):20-39. PubMed ID: 9010647 [TBL] [Abstract][Full Text] [Related]
87. [5-HT3 receptor antagonist als analgetics in rheumatic diseases]. Müller W; Fiebich BL; Stratz T Z Rheumatol; 2006 Oct; 65(6):546, 548-52. PubMed ID: 16450149 [TBL] [Abstract][Full Text] [Related]
88. Treatment of systemic sclerosis with the 5-HT3 receptor antagonist tropisetron. Stratz T; Müller W Scand J Rheumatol Suppl; 2004; 119():59-62. PubMed ID: 15515417 [TBL] [Abstract][Full Text] [Related]
89. 5-HT3 receptor antagonists: new promising therapeutic agents in diabetes and its complications. Rahimian R; Ejtemaei Mehr S; Fakhfouri G; Dehpour AR Acta Med Iran; 2013; 51(10):736. PubMed ID: 24338152 [No Abstract] [Full Text] [Related]
92. Local injections of serotonin type-3 receptor antagonists as a therapeutic option in rheumatology. Seidel MF Future Med Chem; 2012 Apr; 4(6):705-7. PubMed ID: 22530634 [No Abstract] [Full Text] [Related]
93. 3B but which 3B and that's just one of the questions: the heterogeneity of human 5-HT3 receptors. Jensen AA; Davies PA; Bräuner-Osborne H; Krzywkowski K Trends Pharmacol Sci; 2008 Sep; 29(9):437-44. PubMed ID: 18597859 [TBL] [Abstract][Full Text] [Related]